EP
MRTX

Edgestream Partners’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History

Edgestream Partners’s Portfolio MRTX Stock Details MRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-15,453
Closed -$575K – 951
2023
Q1 		$575K Buy
+15,453
New +$575K 0.06% 387
2022
Q4 		– Sell
-40,629
Closed -$2.84M – 663
2022
Q3 		$2.84M Buy
+40,629
New +$2.84M 0.22% 158